# Q8, Q9, & Q10 Questions and Answers -- Appendix:  Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider) – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/q8-q9-q10-questions-and-answers-appendix-qas-from-training-sessions-q8-q9-q10-points-to-consider/74f08aab-1b94-4f9f-8da0-2725af03d078

> FDA guidance document: Q8, Q9, & Q10 Questions and Answers -- Appendix:  Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider). Issue date: August 13, 2012. Get complete insights and analysis.

---

## Details

- Title: Q8, Q9, & Q10 Questions and Answers -- Appendix:  Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider)
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2012-08-13
- Last Changed: 2020-04-15

## Related Documents

- [S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use](https://www.keypedia.com/guidances/guidance-document/s2r1-genotoxicity-testing-and-data-interpretation-for-pharmaceuticals-intended-for-human-use/bdcb4e58-2f39-40e7-90c5-9f222d9203c1)
- [E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1)](https://www.keypedia.com/guidances/guidance-document/e3-structure-and-content-of-clinical-study-reports-questions-and-answers-r1/5b7e3d17-9b0a-44df-bfcf-df3fae8991ae)
- [Q11 Development and Manufacture of Drug Substances](https://www.keypedia.com/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)